Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pietro Invernizzi

Showing results (381-390 of 420) with videos related to

Pageof 42
Sort By:
Journal of Hepatology|August 22, 2025
Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitisFabio Del Zompo, Emilie Crouchet, Tessa Ostyn, et al.
The American Journal of Gastroenterology|July 4, 2020
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline PhosphataseCarla F Murillo Perez, Maren H Harms, Keith D Lindor, et al.
Nature Reviews. Gastroenterology & Hepatology|July 2, 2020
Cholangiocarcinoma 2020: the next horizon in mechanisms and managementJesus M Banales, Jose J G Marin, Angela Lamarca, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary CholangitisAlessio Gerussi, Davide Paolo Bernasconi, Sarah Elisabeth O'Donnell, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2023
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survivalC Fiorella Murillo Perez, Stephanie Ioannou, Iman Hassanally, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2026
Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases-A Cross-Sectional Multicentre StudyNatalie Uhlenbusch, Romée J A L M Snijders, Meike Mund, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 6, 2023
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severityPhilip R Tedbury, Candela Manfredi, Frauke Degenhardt, et al.
Hepatology (Baltimore, Md.)|February 19, 2025
Health-related quality of life is impaired in people with autoimmune hepatitis: Results of a multicentre cross-sectional study within the European Reference NetworkRomée J A L M Snijders, Maciej K Janik, Meike Mund, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2019
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life studyRoberta D'Ambrosio, Luisa Pasulo, Alessia Giorgini, et al.
Journal of Autoimmunity|September 11, 2022
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitisCumali Efe, Koray Taşçılar, Alessio Gerussi, et al.
Pageof 42

Showing results (381-390 of 420) with videos related to

Sort By:
Pageof 42
Journal of Hepatology|August 22, 2025
Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitisFabio Del Zompo, Emilie Crouchet, Tessa Ostyn, et al.
The American Journal of Gastroenterology|July 4, 2020
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline PhosphataseCarla F Murillo Perez, Maren H Harms, Keith D Lindor, et al.
Nature Reviews. Gastroenterology & Hepatology|July 2, 2020
Cholangiocarcinoma 2020: the next horizon in mechanisms and managementJesus M Banales, Jose J G Marin, Angela Lamarca, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 11, 2020
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary CholangitisAlessio Gerussi, Davide Paolo Bernasconi, Sarah Elisabeth O'Donnell, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2023
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survivalC Fiorella Murillo Perez, Stephanie Ioannou, Iman Hassanally, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2026
Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases-A Cross-Sectional Multicentre StudyNatalie Uhlenbusch, Romée J A L M Snijders, Meike Mund, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 6, 2023
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severityPhilip R Tedbury, Candela Manfredi, Frauke Degenhardt, et al.
Hepatology (Baltimore, Md.)|February 19, 2025
Health-related quality of life is impaired in people with autoimmune hepatitis: Results of a multicentre cross-sectional study within the European Reference NetworkRomée J A L M Snijders, Maciej K Janik, Meike Mund, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2019
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life studyRoberta D'Ambrosio, Luisa Pasulo, Alessia Giorgini, et al.
Journal of Autoimmunity|September 11, 2022
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitisCumali Efe, Koray Taşçılar, Alessio Gerussi, et al.
Pageof 42